Selective calcium antagonists with a primary effect on blood vessels. Derivatives of dihydropyridine.
- Arterial hypertension; ischemic heart disease: chronic stable angina, vasospastic angina (Prinzmetal angina).
Hypersensitivity to the active substance or to any of the components of the drug; hypersensitivity to other dihydropyridines; cardiogenic shock, severe aortic stenosis; porphyria; a condition during a myocardial infarction or for a month after it; secondary prevention of myocardial infarction; combination with rifampicin (due to inability to achieve effective levels of nifedipine in plasma due to induction of enzymes); unstable angina; inflammatory bowel disease or Crohn's disease.
The tablets are round, covered with a coating, yellow, the upper and lower surfaces of which are convex. On the fracture, when viewed under a magnifying glass, one can see a nucleus surrounded by a single continuous layer.
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of the reach of children.